Bifidobacteria and its efficacy for the regulation of cholesterol
One of the most frustrating aspects of medical innovations and alleged breakthroughs is trying to sift and distinguish between wishful thinking and cynical exploitation of the facts for potential profit, and the tangible benefits that said discovery has for the population at large. This is an issue that has been significantly amplified by virtue of the alternative health industry as a whole which has been culpable to a near criminal degree with regards to over-hyping the alleged health benefits of certain food items and commodities.Because of this highly uneasy status quo, this has meant that the introduction of probiotics as a viable medical treatment has been a revelation that has been greeted with a tangible degree of suspicion, paranoia and stern disapproval. Even with a series of robust and comprehensive scientific research studies commissioned by various, highly respected institutes from across the world, there are diehard critics within the medical profession who refuse to see reason.
However, it would seem that there is one strain of probiotic that has managed to prove itself as the exception to this uncomfortable impasse: the Bifidobacteria. Bifidobacteria are bacteria that make up the colon flora and some are used in probiotic foods. Although less known compared with Lactobacillus acidophilus, Bifidobacteria has been lauded as the latest and greatest breakthrough in the field of immunology, and this comes as welcome news because it means that the traditional forms of dealing with viral infections and harmful bacteria, antibiotics, can finally be superseded by a more reliable payload delivery system.Bifidobacteria has been identified as a viable treatment option for the control and more effective regulation of dangerously high cholesterol levels; a significant breakthrough for people who have a history of cardiovascular pathologies. Cholesterol has been identified as one of the primary risk factors involved in the onset of a myriad of cardiovascular diseases, including myocardiac infarction, stroke and the depositing of arterial plaque within the chamber of the heart.
Cholesterol as a whole is not a negative thing, indeed, it plays a vital role within the body as it serves to provide a reliable lubricant for the liver among other, essential physiological properties. However, when cholesterol reaches dangerously high levels, this significantly elevates the risk of cardiovascular pathology setting in, including hypertension.In essence, cholesterol is measured according to a ratio of two similar compounds which are known as:
Low density lipids
High density lipids
LDL’s have been identified as being the compound responsible for the onset of cardiovascular dysfunction, and so the Bifidobacteria is a reliable means of ensuring that the LDL/HDL ratio is more closely and effectively regulated, to avoid potential complications further down the line.
Studies have identified that Bifidobacteria manages to achieve this by optimising the rate at which bile salts are removed from waste products which remain dormant within the gastrointestinal system.
